Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Tolperisone on Drowsiness and Simulated Driving Performance
NCT04407377Phase 1Completed
- Sponsor
- Neurana Pharmaceuticals, Inc.
- Start
- Jun 2020
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of tolperisone in muscle spasm (4 arms), sponsored by Neurana Pharmaceuticals, Inc. Primary endpoint: Driving Performance (Standard Deviation of Lateral Position) at Day 1. Started Jun 2020; status: completed.
02
Drugs
tolperisone
03
Conditions
muscle spasm
Beyond the preview
Go deeper on NCT04407377.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04407377.